Core Viewpoint - Jinhai Medical Technology (02225) has seen a significant stock increase of over 13%, currently trading at 1.29 HKD, with a transaction volume of 13.0365 million HKD, following the announcement of a strategic cooperation framework agreement with Medtronic for the promotion of real-time navigation tracking endoscopic spine technology in China [1] Group 1: Strategic Cooperation - Jinhai Medical Technology's subsidiary, Jinhai Shanghai, has entered into a strategic cooperation framework agreement with Medtronic Changzhou to develop a leading domestic and internationally advanced integrated solution for navigation endoscopic spine technology [1] - The partnership aims to address clinical needs, organize domestic and international academic exchange activities, and promote the clinical academic exchange and technological advancement of real-time navigation tracking endoscopic spine technology in China [1] - Both parties will provide navigation endoscopic spine prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of the technology [1] Group 2: Upcoming Events - The 8th China International Import Expo (CIIE) will be held in Shanghai from November 5 to 10, during which Jinhai Medical Technology will jointly launch the latest developed navigation endoscopic spine innovation technology with Medtronic China [1] - This new technology is expected to be applicable in spinal surgery, paving the way for precision and intelligent development in spinal procedures, while also shortening the learning curve for clinicians in endoscopic spine technology [1] - The initiative is anticipated to facilitate more efficient and widespread clinical applications in the future [1]
港股异动 | 今海医疗科技(02225)再涨超13% 附属与美敦力常州达成合作 共拓脊柱内窥镜导航技术市场